Delivery Order SPE2DB20D3103-SPE2DB26FL4G7
- Not listed
- The Defense Logistics Agency awarded a $16,066.48 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of September 26, 2025. This competitive, non-set-aside contract employs firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply contract vehicle...
- The Defense Logistics Agency awarded a $44,381.09 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion targeted for August 12, 2025. This competitive, non-set-aside award reflects firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a ceiling value of $1,957.32. This competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under a larger contract vehicle, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $11,725.57 and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as...
- The Defense Logistics Agency awarded a $2,398.68 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price, non-set-aside contract with a completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.34 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication in 3 mL vials, with a contract ceiling value of $17,734.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters. The...
- The Defense Logistics Agency awarded a $3,744.69 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order through its corporate office division. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.32 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4G7Delivery Order
The Defense Logistics Agency awarded a $14,544.96 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials on October 29, 2025, with completion by October 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The order represents a child delivery order against AmerisourceBergen's larger pharmaceutical supply vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical supply agreement extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications, vaccines, and medical supplies to support military healthcare programs and other federal medical systems. The Ozempic procurement falls within the company's established portfolio of diabetes and specialty pharmaceutical products delivered through the DLA Medical Supply Chain to support military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 10/29/25 |